Supplementary Table 1 from A Phase I Study of Quisinostat (JNJ-26481585), an Oral Hydroxamate Histone Deacetylase Inhibitor with Evidence of Target Modulation and Antitumor Activity, in Patients with Advanced Solid Tumors

Balaji Venugopal, Richard Baird,Rebecca S. Kristeleit, Ruth Plummer,Richard Cowan, Adam Stewart, Nele Fourneau,Peter Hellemans,Yusri Elsayed,Steve Mcclue, Johan W. Smit, Ann Forslund,Charles Phelps, John Camm, T.R. Jeffry Evans,Johann S. de Bono,Udai Banerji

openalex（2023）

引用 0|浏览4

暂无评分

摘要

Supplementary Table 1 - PDF file 54K, Number (percentage) of patients exhibiting increased ventricular ectopic activity

查看译文

关键词

antitumor activity,inhibitor,quisinostat,solid tumors

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要